Compare Abbott Laboratories (ABT) vs Invesco DB Agriculture Fund (DBA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Invesco DB Agriculture Fund — how do they compare? Abbott Laboratories trades at $95.58 (market cap $166.94B), while Invesco DB Agriculture Fund trades at $27.59. The key difference: Abbott Laboratories pays a 2.63% dividend while Invesco DB Agriculture Fund pays none, and Invesco DB Agriculture Fund is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | DBA | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | — |
52-Week High | $136.62 | $28.73 |
52-Week Low | $82.57 | $25.44 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
DBA (Invesco DB Agriculture Fund) trades at $27.54, up 2.99% with strong bullish technical signals from moving averages. The fund tracks agricultural commodities including corn, soybeans, and livestock futures. Recent news highlights supply disruptions in Brazil's coffee harvest and China's $17 billion crop purchase commitment through 2028, creating favorable conditions for agricultural ETFs.
The agricultural commodity rally presents upside potential, though overbought RSI readings suggest near-term consolidation. Key risks include weather volatility affecting crop yields and geopolitical impacts on global trade flows. The fund's diversified exposure offers hedging benefits against inflation but remains sensitive to commodity price swings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Invesco DB Agriculture Fund
The index, which is comprised of one or more underlying commodities ("index commodities"), is intended to reflect the agricultural sector. The fund pursues its investment objective by investing in a portfolio of exchange-traded futures.
Read more on DBA →
